🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

CG Oncology, Inc.

CGON Healthcare
$62.29 +$1.56 (2.57%)
Market Cap: $5.49 B
Gurus Holding
3
Popularity Rank
#3234
% of Shares Held
1.11%
Net Activity (Q1 2026)
+$48.39 M

Guru Ownership Trend

Guru Analysis for CG Oncology, Inc. (CGON)

CG Oncology, Inc. (CGON), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $60.97 M.

Top institutional holders include Ken Fisher and Steven Cohen.

Institutional sentiment is currently Bullish. This is evidenced by a $48.39 M net inflow during the quarter.

Recent activity highlights Steven Cohen who increased their stake by 163.9%.

Key Holders

Top 5 by Value

$31.47 M
$27.03 M
$7.74 M

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$48.39 M
Total Buy Value
New Buys 1
Additions 2
-$0
Total Sell Value
Reductions 0
Sold Out 0

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
0
Net Buyers
3

FAQs for CG Oncology, Inc. (CGON)

Major holders include Ken Fisher ($31.47 M), Steven Cohen ($27.03 M), Cliff Asness ($7.74 M). According to the latest reported data, 3 tracked investment managers collectively hold approximately 978,767 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $48.39 M, with 3 managers increasing positions and 0 managers reducing holdings.

No tracked managers reduced or fully exited their positions in CGON during the most recent reporting period.

Yes, 1 managers opened new positions in CGON, and 2 increased their existing holdings. The total reported buy value was $48.39 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.01% New Buy 465,033 $31.47 M Q1 2026
0.03% Add 163.9% 399,392 $27.03 M Q1 2026
0.00% Add 1.8% 114,342 $7.74 M Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form